Coloplast Rises as Carnegie Upgrades to Buy on Organic Growth Prospects

• (PLX AI) - Coloplast shares rose 3.4% as analysts at Carnegie upgraded the stock to buy from hold, seeing stronger organic growth prospects.
• • Price target raised to DKK 1,100 from DKK 1,050.
• • After buying Atos Medical, Coloplast is raising the stability of its earnings, Carnegie said
• • With Atos products, and Coloplast's own new offerings to be introduced in the next 3 years, the company is likely to boost its organic growth: Carnegie